SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
Jarlhelt I, Nielsen S, Jahn C, Hansen C, Pérez-Alós L, Rosbjerg A, Bayarri-Olmos R, Skjoedt M, Garred P. SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation. Frontiers In Immunology 2021, 12: 767981. PMID: 34804055, PMCID: PMC8596567, DOI: 10.3389/fimmu.2021.767981.Peer-Reviewed Original ResearchConceptsSARS-CoV-2-specific antibodiesSARS-CoV-2 receptor-binding domainReceptor-binding domainComplement activationAntibody responseInflammatory responseSARS-CoV-2 antibody responseDisease severitySevere acute respiratory syndrome coronavirus 2Fc gamma receptor engagementAcute respiratory syndrome coronavirus 2COVID-19 disease severitySARS-CoV-2 antibodiesSARS-CoV-2 infectionRespiratory syndrome coronavirus 2Pro-inflammatory cytokines TNFAntibody-mediated complement activationProminent complement activationSpecific antibodiesSyndrome coronavirus 2COVID-19 severitySerious public health threatCoronavirus disease 2019Classical complement pathway activationClassical complement activation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply